April 19, 2024 Bitcoin Halving: Catalyst for New Price Heights?
April 18, 2024 EU Moves Toward Single Capital Market Union
April 17, 2024 Bitcoin Halving 2024: Market Impact Predictions
April 14, 2024 Markets Rattle: Iran-Israel Conflict and Economic Data Ahead
Microsoft Q3 Preview: Focusing On Copilot
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading
Journey Medical (DERM) stock forecast for 2026
Updated: April 18, 2024 (16:47)
Sector: HealthcareThe share price of Journey Medical Corp. (DERM) now
50/200 Day Moving Average: $3.894 / $3.689
This figure corresponds to the Average Price over the previous 50/200 days. For Journey Medical stocks, the 50-day moving average is the resistance level today.
For Journey Medical stocks, the 200-day moving average is the resistance level today.
Are you interested in Journey Medical Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Journey Medical stock price in 2026. How much will one Journey Medical share be worth in 2026? Is it worth taking profit / loss on DERM stock now or waiting? What are analysts' forecasts for Journey Medical stock?
We forecast Journey Medical stock performance using neural networks based on historical data on DERM stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Journey Medical Corp. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Journey Medical analysts is $7.83. Today 200 Day Moving Average is the resistance level (3.689 $). 50 Day Moving Average is the resistance level (3.894 $).
Historical and forecast chart of Journey Medical Corp. stock
The chart below shows the historical price of Journey Medical stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the DERM stock price can be found in the table below.
Journey Medical Corp. operates as a commercial-stage pharmaceutical company, which engages in developing, acquiring, licensing and commercializing of dermatology products. It s focused on identifying, acquiring and strategically commercializing innovative, differentiated dermatology products through its sales and marketing model. The company was founded by Claude Maraoui in October 2014 and is headquartered in Scottsdale, AZ.
Journey Medical (DERM) Forecast for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 6.45 | 5.88 | 7.05 | 16.54 % |
| Feb | 6.77 | 6.37 | 6.99 | 8.84 % |
| Mar | 7.31 | 6.90 | 8.04 | 14.12 % |
| Apr | 7.08 | 6.45 | 7.75 | 16.81 % |
| May | 8.13 | 7.72 | 8.90 | 13.30 % |
| Jun | 8.17 | 7.57 | 9.02 | 16.09 % |
| Jul | 9.34 | 8.75 | 10.28 | 14.83 % |
| Aug | 8.02 | 7.20 | 8.42 | 14.48 % |
| Sep | 7.71 | 7.08 | 8.48 | 16.45 % |
| Oct | 7.64 | 7.39 | 8.40 | 11.94 % |
| Nov | 6.64 | 6.04 | 7.38 | 18.13 % |
| Dec | 7.53 | 6.58 | 8.25 | 20.29 % |
Journey Medical information and performance
9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE, AZ, US
Market capitalization of the Journey Medical Corp. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of DERM shares in the company outstanding by the market price of one share.
EBITDA of Journey Medical is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Journey Medical price target for 2026 by month
Target values for the price of one Journey Medical share for Jan 2026.
In Jan, the Negative dynamics for Journey Medical Corp. shares will prevail with possible monthly volatility of 16.545% volatility is expected.
Pessimistic target level: 5.88
Optimistic target level: 7.05
Target values for the price of one Journey Medical share for Feb 2026.
In Feb, the Positive dynamics for Journey Medical Corp. shares will prevail with possible monthly volatility of 8.837% volatility is expected.
Pessimistic target level: 6.37
Optimistic target level: 6.99
Target values for the price of one Journey Medical share for Mar 2026.
In Mar, the Positive dynamics for Journey Medical Corp. shares will prevail with possible monthly volatility of 14.119% volatility is expected.
Pessimistic target level: 6.90
Optimistic target level: 8.04
Target values for the price of one Journey Medical share for Apr 2026.
In Apr, the Negative dynamics for Journey Medical Corp. shares will prevail with possible monthly volatility of 16.813% volatility is expected.
Pessimistic target level: 6.45
Optimistic target level: 7.75
Target values for the price of one Journey Medical share for May 2026.
In May, the Positive dynamics for Journey Medical Corp. shares will prevail with possible monthly volatility of 13.304% volatility is expected.
Pessimistic target level: 7.72
Optimistic target level: 8.90
Target values for the price of one Journey Medical share for Jun 2026.
In Jun, the Positive dynamics for Journey Medical Corp. shares will prevail with possible monthly volatility of 16.087% volatility is expected.
Pessimistic target level: 7.57
Optimistic target level: 9.02
Target values for the price of one Journey Medical share for Jul 2026.
In Jul, the Positive dynamics for Journey Medical Corp. shares will prevail with possible monthly volatility of 14.825% volatility is expected.
Pessimistic target level: 8.75
Optimistic target level: 10.28
Target values for the price of one Journey Medical share for Aug 2026.
In Aug, the Negative dynamics for Journey Medical Corp. shares will prevail with possible monthly volatility of 14.482% volatility is expected.
Pessimistic target level: 7.20
Optimistic target level: 8.42
Target values for the price of one Journey Medical share for Sep 2026.
In Sep, the Negative dynamics for Journey Medical Corp. shares will prevail with possible monthly volatility of 16.448% volatility is expected.
Pessimistic target level: 7.08
Optimistic target level: 8.48
Target values for the price of one Journey Medical share for Oct 2026.
In Oct, the Negative dynamics for Journey Medical Corp. shares will prevail with possible monthly volatility of 11.936% volatility is expected.
Pessimistic target level: 7.39
Optimistic target level: 8.40
Target values for the price of one Journey Medical share for Nov 2026.
In Nov, the Negative dynamics for Journey Medical Corp. shares will prevail with possible monthly volatility of 18.129% volatility is expected.
Pessimistic target level: 6.04
Optimistic target level: 7.38
Target values for the price of one Journey Medical share for Dec 2026.
In Dec, the Positive dynamics for Journey Medical Corp. shares will prevail with possible monthly volatility of 20.292% volatility is expected.
Pessimistic target level: 6.58
Optimistic target level: 8.25
